Fifty years after Blumberg’s Nobel Prize-winning discovery of the hepatitis B surface antigen, this episode revisits the milestones that transformed HBV care. From vaccination and antivirals to evolving concepts of cure. The discussion also explores the unanswered questions in HBV biology, the future of curative therapies, and whether global elimination remains within reach.
Sabela Lens (Moderator), Heiner Wedemeyer (Faculty), Thomas Tu (Patient representative), Nikolai Naoumov (Faculty)